These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9073316)

  • 1. Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells.
    Asakura T; Takahashi N; Takada K; Inoue T; Ohkawa K
    Anticancer Drugs; 1997 Feb; 8(2):199-203. PubMed ID: 9073316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.
    Ohkawa K; Hatano T; Tsukada Y; Matsuda M
    Br J Cancer; 1993 Feb; 67(2):274-8. PubMed ID: 8431358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
    Asakura T; Ohkawa K; Takahashi N; Takada K; Inoue T; Yokoyama S
    Br J Cancer; 1997; 76(10):1333-7. PubMed ID: 9374380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracellular distribution of bovine serum albumin-conjugated doxorubicin and multidrug resistance].
    Takahashi N; Asakura T; Ohkawa K; Fukuda K; Aoki T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):87-92. PubMed ID: 9020950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma.
    Ohkawa K; Hatano T; Yamada K; Joh K; Takada K; Tsukada Y; Matsuda M
    Cancer Res; 1993 Sep; 53(18):4238-42. PubMed ID: 8364920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic analysis of protein-conjugated doxorubicin (DXR) and its degraded adducts in DXR-sensitive and -resistant rat hepatoma cells.
    Takahashi N; Asakura T; Ohkawa K
    Anticancer Drugs; 1996 Aug; 7(6):687-96. PubMed ID: 8913438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cytocidal activity and glutathione-S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione with different substrate specificity.
    Hashizume Y; Asakura T; Oikawa T; Yamauchi T; Soda K; Ohkawa K
    Anticancer Drugs; 2001 Jul; 12(6):549-54. PubMed ID: 11460002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
    Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
    Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R; Caminada D; Loncar J; Fent K; Smital T
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells.
    Asakura T; Hashizume Y; Tashiro K; Searashi Y; Ohkawa K; Nishihira J; Sakai M; Shibasaki T
    Int J Cancer; 2001 Oct; 94(2):171-7. PubMed ID: 11668494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate.
    Tashiro K; Asakura T; Fujiwara C; Ohkawa K; Ishibashi Y
    Anticancer Drugs; 2001 Sep; 12(8):707-12. PubMed ID: 11604559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
    Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
    Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine.
    Fujita R; Ishikawa M; Takayanagi M; Takayanagi Y; Sasaki K
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):281-4. PubMed ID: 11031728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic changes in protein-kinase-C activity and isoforms in ah66 cells during the acquisition of multidrug-resistant phenotype.
    Ohkawa K; Hatano T; Isonishi S; Takada K; Joh K; Matsuda M
    Oncol Rep; 1994 May; 1(3):551-5. PubMed ID: 21607402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-peptide conjugates overcome multidrug resistance.
    Mazel M; Clair P; Rousselle C; Vidal P; Scherrmann JM; Mathieu D; Temsamani J
    Anticancer Drugs; 2001 Feb; 12(2):107-16. PubMed ID: 11261883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin.
    Bennis S; Faure P; Chapey C; Hu YP; Fourche J; El Yamani J; Robert J
    Anticancer Drugs; 1997 Jul; 8(6):610-7. PubMed ID: 9300576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
    Abulrob AN; Mason M; Bryce R; Gumbleton M
    J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R; Morjani H; Manfait M
    Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.